• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Quintiles to Partner with Japanese Lab Company Medca

Quintiles to Partner with Japanese Lab Company Medca

March 31, 2008
CenterWatch Staff

Research Triangle Park, N.C.-based CRO Quintiles inked an agreement with Medca Japan, a laboratory testing and nursing care services company based outside Tokyo in Saitama, to use its lab to support clinical trials in the country. Medca Japan’s facility and staff are College of American Pathologists (CAP)-certified and its data will be available on Quintiles’ QNET database. Quintiles stated that Japanese regulations are changing in a positive way and are now allowing pivotal clinical trials to be conducted outside of Japan into the greater Asia region.

The challenge has been finding laboratories in the region that are “harmonized” with the same standards, the company stated. Quintiles now has central lab coverage in the Asia-Pacific region through a network of CAP-certified labs in Beijing, Singapore, Mumbai and now Japan.

Founded in 1974, Medca reported $340 million in revenue in 2007 and is also a medical supply manufacturer and distributor. It is also a leading pharmaceutical importer and seller in the country. The partnership is headed by Alan Ong, vice president and general manager, Quintiles Labs Asia, and Yoh Narimatsu, president, Quintiles Japan.

“We have established excellent systems for providing high-quality central laboratory services based on Quintiles’ global standard. We are determined to continue to increase clinical trials in Japan and provide superior services for our customers through this strategic business alliance,” said Narimatsu.

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 16Oct

    WCG MAGI's Clinical Research Hybrid Conference - 2022 West

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Protocol-360x240.png

    Avoid Deviations by Making Protocol Review a Team Effort

  • SelectionProcess-360x240.png

    Give Us a Voice: Sites Clamor for a Say on Vendor Selection

  • Convince-360x240.png

    Use Data and Details to Convince Site Leadership to Add Staff

  • AsktheExpertsBadge-360x240.png

    Ask the Experts: Listing Trial Staff and Others on the Statement of Investigator

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing